Release Date: 17/04/12 11:08 Summary: Announcement of buy-back - Appendix 3C Price Sensitive: Yes Download Document 80.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%